All 4 MRGs of the risk model, ETFB, CPT1A, HPDL, and IDH3A, were risk-associated and highly expressed in the high-risk group, indicating potential roles of these genes in the development of AML. This evidence concerns the gene HPDL and acute myeloid leukemia.